| Financial Year |
March 31 2023 |
| Monetary Funds |
301,140,145.92 |
| Held-for-trading Financial Assets |
50,000,000.00 |
| Notes Receivable |
27,378,101.30 |
| Accounts Receivable |
255,574,919.68 |
| Advances to Suppliers |
22,134,459.52 |
| Other Receivables |
17,542,892.30 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
527,748.98 |
| Dividend Receivable |
-- |
| Inventories |
165,019,557.86 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,903,809.58 |
| Total Current Assets |
854,749,725.41 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
120,677,686.06 |
| Investment Properties |
-- |
| Fixed Assetes |
18,882,086.79 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
29,371,551.84 |
| R&D expenses |
1,683,102.35 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
792,232.78 |
| Deferred Income Tax Assets |
21,383,396.19 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
199,229,119.66 |
| Total Assets |
1,053,978,845.07 |
| Short-Term Loans |
10,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
90,774,584.50 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
62,370.76 |
| Taxes Payable |
18,461,171.11 |
| Interest Payable |
-- |
| Dividend Payable |
218,159.93 |
| Other payables |
19,098,342.99 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,666,037.22 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
197,900,505.54 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
320,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,145,376.36 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
10,312,112.73 |
| Total Liabilities |
208,212,618.27 |
| Paid-In Capital(Or Share Stock) |
197,590,862.00 |
| Capital Surplus |
296,500,894.80 |
| Surplus Reserve |
37,078,655.59 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
316,192,732.82 |
| Minority Stockholder's Interest |
-1,511,918.41 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
847,278,145.21 |
| Owner's Equity（Stockholder's Equity） |
845,766,226.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,053,978,845.07 |
